Abstract
Inadvertent extravasation during intravenous antitumor therapy is not an unusal complication and can cause damage ranging from minor erythema to severe local necrosis. The appropriate management of these iatrogenic accidents as a part of supportive care in oncology has been addressed by several experimental studies, but there has been little clinical study and no coclusive evidence on the best therapeutic strategies to adopt. The case reported here of a patient suffering from severe softtissue injury caused by extravasation of epidoxorubicin demonstrates the usefulness of a combined management (medical, surgical and rehabilitative) in the appropriate care of extravasation.
This is a preview of subscription content, log in via an institution to check access.
References
Bertelli G, Dini D, Forno G, Gozza A, Venturini M, Ballella G, Rosso R (1993) Dimethylsulphoxide and cooling after extravasation of antitumor agents (letter). Lancet 341:1098–1099
Dorr RT, (1990) Antidotes to vesicant chemotherapy extravasation. Blood Rev 4:41–60
Dorr RT, Alberts DS, Chen HSG (1980) Experimental model of doxorubicin extravasation in the mouse. J Pharmacol Methods 4:321–334
Dorr RT, Alberts DS, Stone A (1985) Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep 69:431–437
Gallina EJ (1993) Practical guide to chemotherapy administration for physicians and oncology nurses. In: DeVita V, Hellman S, Rosemberg SA (eds) Cancer. Principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 2570–2580
Kitcher SS, Partridge CJ (1991) A review of low level laser therapy. Physiotherapy 77:161–168
Larson DL (1985) What is the appropriate management of tissue extravasttion by antitumor agents? Plast Reconstr Surg 75:397–402
Lawrence HJ, Walsh D, Zapotowski KA, et al (1989) Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 23:316–318
Ludwig CU, Stoll HR, Obrist R, Obrecht JP (1986) Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherol. Eur J Cancer Clin Oncol 23: 327–329
Lyons RF, Abergel RP, Rodney AW, et al (1987) Biostimulation of wound healing in vivo by a helium-neon laser. Ann Plast Surg 18: 47–50
Olver IN, Aisner J, Hament A, et al (1988) A prospective study of topical dimethylsulfoxide for treating anthracycline extravasation. J Clin Oncol 6:1732–1735
Preuss P, Partoft S (1987) Cytostatic extravasations. Ann Plast Surg 19: 323–327
VanSloten Harwood K (1987) Treatment of anthracycline extravasation—recommendations for practice. J Clin Oncol 5: 1705
Wetmore N (1985) Extravasation: the dreaded complication. National Intravenous Therapy Association 8: 47–49
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dini, D., Forno, G., Gozza, A. et al. Combined management in the treatment of epidoxorubicin extravasation. Support Care Cancer 3, 150–152 (1995). https://doi.org/10.1007/BF00365857
Issue Date:
DOI: https://doi.org/10.1007/BF00365857